Drug intelligence / Profile preview

lskl

Development stage
Preclinical
Lead developer
AnaSpec
Modality
Peptides
Administration
Intraperitoneal, Intravenous (preclinical/animal Use)
01

Overview

LSKL is a **tetrapeptide (Leu-Ser-Lys-Leu)** derived from the latency-associated peptide (LAP) region of TGF-β and functions as a **competitive antagonist of transforming growth factor-β1 (TGF-β1)** by inhibiting thrombospondin-1 (TSP-1)-mediated activation of TGF-β1. By blocking the interaction between TSP-1 and LAP, LSKL **prevents progression of fibrotic diseases** such as renal interstitial fibrosis and hepatic fibrosis, and has been shown to alleviate subarachnoid fibrosis, hydrocephalus, and improve cognitive function after subarachnoid hemorrhage in preclinical models. LSKL can cross the blood-brain barrier and is primarily used as a research tool; it is not an approved therapeutic and is for research use only[1][5][7][9][10].

Other names
LSKL peptideThrombospondin (TSP-1) InhibitorLeu-Ser-Lys-Leu peptide
02

Targets

THBS1 (Thrombospondin-1)LAP/TGF-beta-1 (Transforming growth factor beta-1 latency-associated peptide/latent TGF-beta-1 complex)TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on lskl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lskl.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call